Use of torsades de pointes risk drugs among patients with out-of-hospital cardiac arrest and likelihood of shockable rhythm and return of spontaneous circulation: A nationwide study

Autor: Johanna Krøll, Camilla H.B. Jespersen, Søren Lund Kristensen, Emil L. Fosbøl, Naja Emborg Vinding, Freddy Lippert, Kristian Kragholm, Christian Jøns, Steen M. Hansen, Lars Køber, Peter Karl Jacobsen, Jacob Tfelt-Hansen, Peter E. Weeke
Rok vydání: 2022
Předmět:
Zdroj: Krøll, J, H. B. Jespersen, C, Lund Kristensen, S, Fosbøl, E L, Emborg Vinding, N, Lippert, F, Kragholm, K, Jøns, C, Hansen, S M, Køber, L, Karl Jacobsen, P, Tfelt-Hansen, J & Weeke, P E 2022, ' Use of torsades de pointes risk drugs among patients with out-of-hospital cardiac arrest and likelihood of shockable rhythm and return of spontaneous circulation : a nationwide study ', Resuscitation, vol. 179, pp. 105-113 . https://doi.org/10.1016/j.resuscitation.2022.08.008
ISSN: 1873-1570
DOI: 10.1016/j.resuscitation.2022.08.008
Popis: Aim: Treatment with certain drugs can augment the risk of developing malignant arrhythmias (e.g. torsades de pointes [TdP]). Hence, we examined the overall TdP risk drug use before out-of-hospital cardiac arrest (OHCA) and possible association with shockable rhythm and return of spontaneous circulation (ROSC). Methods: Patients ≥18 years with an OHCA of cardiac origin from the Danish Cardiac Arrest Registry (2001–2014) and TdP risk drug use according to www.CredibleMeds.org were identified. Factors associated with TdP risk drug use and secondly how use may affect shockable rhythm and ROSC were determined by multivariable logistic regression. Results: We identified 27,481 patients with an OHCA of cardiac origin (median age: 72 years [interquartile range 62.0, 80.0 years]). A total of 37% were in treatment with TdP risk drugs 0–30 days before OHCA compared with 33% 61–90 days before OHCA (p < 0.001). Most commonly used TdP risk drugs were citalopram (36.1%) and roxithromycin (10.7%). Patients in TdP risk drug treatment were older (75 vs 70 years) and more comorbid compared with those not in treatment. Subsequently, TdP risk drug use was associated with less likelihood of the presenting rhythm being shockable (odds ratio [OR] = 0.63, 95% confidence interval [CI]:0.58–0.69) and ROSC (OR = 0.73, 95% CI:0.66–0.80). Conclusion: TdP risk drug use increased in the time leading up to OHCA and was associated with reduced likelihood of presenting with a shockable rhythm and ROSC in an all-comer OHCA setting. However, patients in TdP risk drug treatment were older and more comorbid than patients not in treatment.
Databáze: OpenAIRE
Externí odkaz: